TANYA MIMS: Open Payments
NPI 1326512732 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 25 payments from 12 companies in 2025. Trend: 2023 $713 · 2024 $1,894 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $128 |
| ViiV Healthcare Company | 4 | $107 |
| GENZYME CORPORATION | 4 | $106 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Pharming Healthcare, Inc. | 1 | $29 |
| CSL Behring | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| PFIZER INC. | 1 | $20 |
Products named: DUPIXENT, NUCALA, CABENUVA, TRELEGY ELLIPTA, RUCONEST, Hizentra, TEZSPIRE, EBGLYSS.
Industry payments across GA — which companies pay providers there.
